Wang, Zhizhi
University of Washington
9 papers on CoChatORCID 0000-0003-4948-925X
Most cited papers
- Verified
MeCP2 Suppresses Nuclear MicroRNA Processing and Dendritic Growth by Regulating the DGCR8/Drosha Complex
Cheng, T.-L., Wang, Z., Liao, Q., Zhu, Y., Zhou, W.-H., Xu, W., & Qiu, Z. (2014) · Developmental Cell
Genetics and Neurodevelopmental DisordersMicroRNA in disease regulation
Cited by 270
- Verified
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Sangodkar, J., Perl, A., Tohme, R., Kiselar, J., Kastrinsky, D. B., Zaware, N., Izadmehr, S., Mazhar, S., Wiredja, D. D., O’Connor, C. M., et al. (2017) · Journal of Clinical Investigation
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 196
- Verified
Selective PP2A enhancement through biased heterotrimer stabilization
Leonard, D., Huang, W., Izadmehr, S., O’Connor, C. M., Wiredja, D. D., Wang, Z., Zaware, N., Chen, Y., Schlatzer, D. M., Kiselar, J., et al. (2020) · Cell
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 176
- Verified
Crystal structure of a membrane-bound O-acyltransferase
Ma, D., Wang, Z., Merrikh, C. N., Lang, K. S., Lu, P., Li, X., Merrikh, H., Rao, Z., & Xu, W. (2018) · Nature
Bacterial Genetics and BiotechnologyEnzyme Structure and Function
Cited by 105
- Verified
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Wang, J., Okkeri, J., Pavic, K., Wang, Z., Kauko, O., Halonen, T., Sarek, G., Ojala, P. M., Rao, Z., Xu, W., et al. (2017) · The EMBO Reports
Cancer Mechanisms and TherapySignaling Pathways in Disease
Cited by 95
- Verified
Crystal structure of a PP2A B56-BubR1 complex and its implications for PP2A substrate recruitment and localization
Wang, J., Wang, Z., Yu, T., Yang, H., Virshup, D. M., Kops, G. J. P. L., Lee, S. H., Zhou, W., Li, X., Xu, W., et al. (2016) · Protein & Cell
Microtubule and mitosis dynamicsGenomics and Chromatin Dynamics
Cited by 80
- Verified
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
O’Connor, C. M., Leonard, D., Wiredja, D., Avelar, R. A., Wang, Z., Schlatzer, D., Bryson, B., Tokala, E., Taylor, S. E., Upadhyay, A., et al. (2020) · Oncogene
Protein Tyrosine PhosphatasesMelanoma and MAPK Pathways
Cited by 48
- Verified
Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)
Qin, J., Wang, Z., Hoogeveen-Westerveld, M., Shen, G., Gong, W., Nellist, M., & Xu, W. (2016) · Journal of Biological Chemistry
Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancer
Cited by 37
- Verified
Crystal structure of the yeast TSC1 core domain and implications for tuberous sclerosis pathological mutations
Sun, W., Zhu, Y. J., Wang, Z., Zhong, Q., Gao, F., Lou, J., Gong, W., & Xu, W. (2013) · Nature Communications
Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancer
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free